Smart shoe gadget aims to track senior walking patterns
NCT ID NCT07158580
First seen Oct 31, 2025 · Last updated Jun 23, 2026 · Updated 27 times
Summary
This pilot study will test a wearable device called OptiGait that attaches to a shoe to measure walking speed and natural gait. Twenty healthy adults aged 65 and older will walk with and without the device to see if it accurately captures movement. The goal is to refine the device for future use in monitoring mobility.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SENIORS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
University of Wisconsin - Madison
Madison, Wisconsin, 53705, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
OptiGait Wearable Gait Tracker (device)
What this could lead to
If successful, this device could help monitor walking patterns in older adults, potentially aiding fall prevention or mobility assessments.
What could go wrong
This is a very small pilot study (20 people) with no disease focus, so results may not apply to broader populations or clinical settings.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.